10/11/2021 EIP Pharma announces final results of its AscenD-LB phase II clinical study for dementia with Lewy Bodies Science watch
27/10/2021 Panhellenic Federation of Alzheimer’s Disease and Related Disorders is conducting a study into the effects of cannabidiol in Mild Cognitive Impairment Science watch
26/10/2021 Eli Lilly initiates rolling FDA submission for its anti-amyloid drug donanemab in early Alzheimer's disease Science watch
23/10/2021 New study finds that mirtazapine has no effect on agitation in people with dementia Science watch
13/10/2021 Anavex Life Sciences announces the continuation of its Phase IIb/III study for AD following recommendation of the Independent Data Safety Monitoring Board Science watch
08/10/2021 Roche has been granted US FDA Grants Breakthrough Therapy designation for gantenerumab in AD Science watch
06/10/2021 Cassava Sciences initiates a Phase III trial of simufilam for Alzheimer’s disease Science watch
21/09/2021 TouchNEUROLOGY discusses the approval of aducanumab for Alzheimer’s disease, with two experts in the field Science watch
20/09/2021 Gates Notes post highlights the need for early diagnostics for Alzheimer's disease and dementia Science watch
